Ellevest Inc’s Dynavax Technologies DVAX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q2
Sell
-30
Closed -$294 698
2023
Q1
$294 Sell
30
-69
-70% -$737 ﹤0.01% 1730
2022
Q4
$1.05K Sell
99
-58
-37% -$674 ﹤0.01% 1512
2022
Q3
$2K Hold
157
﹤0.01% 1330
2022
Q2
$2K Sell
157
-110
-41% -$1.17K ﹤0.01% 1151
2022
Q1
$3K Buy
267
+75
+39% +$911 ﹤0.01% 1122
2021
Q4
$3K Hold
192
﹤0.01% 1086
2021
Q3
$4K Hold
192
﹤0.01% 1000
2021
Q2
$2K Buy
192
+69
+56% +$627 ﹤0.01% 1027
2021
Q1
$1K Sell
123
-89
-42% -$734 ﹤0.01% 1140
2020
Q4
$1K Sell
212
-87
-29% -$394 ﹤0.01% 1049
2020
Q3
$1K Buy
+299
New +$2.13K ﹤0.01% 991
2020
Q2
Sell
-141
Closed 1172
2020
Q1
$0 Buy
+141
New +$654 ﹤0.01% 1132

Other funds holding DVAX

Ellevest Inc's DVAX Position: Q2 2023 in Review

Ellevest Inc sold out of Dynavax Technologies (DVAX) in Q2 2023, closing a stake of 30 shares — an estimated $294 sold.

Ellevest Inc first reported a position in DVAX in Q1 2020 and held it in 12 quarters. The position peaked at $4K in Q3 2021. 215 funds tracked by Wall St. Rank hold DVAX as of Q2 2023.

  • Ellevest Inc reported no remaining Dynavax Technologies position as of Q2 2023 after selling out during the quarter.
  • Ellevest Inc sold 30 Dynavax Technologies shares in Q2 2023, an estimated $294.
  • Ellevest Inc first reported a position in Dynavax Technologies in Q1 2020 and held it in 12 quarters.
  • Ellevest Inc's Dynavax Technologies position peaked at $4K in Q3 2021.
  • 215 funds tracked by Wall St. Rank held Dynavax Technologies as of Q2 2023.

Based on Ellevest Inc's 13F filing for Q2 2023, filed 9 Aug 2023.